Search

everythinglearnresearchcommunity

for

Search:↓

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

Men with severe hair loss may have poorer sperm quality.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Hair loss linked to higher heart disease risk in both men and women.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Melatonin improved mental health and metabolism in women with PCOS.

*Acorus calamus* has many medicinal benefits but needs more safety research.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.